Companies: 10,795·Total market cap: $144.5T
Spruce Biosciences, Inc.

Spruce Biosciences, Inc.

SPRBNASDAQHealthcare● Active
$49.32
$-1.11(-2.20%)
Market Cap$67668470
P/E Ratio
52W High$838.125
52W Low$7
Overview

Spruce Biosciences, Inc.(SPRB)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · SPRB · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.00B$0.00B$0.01B$0.00B$0.00B
Cost of Revenue$0.00B$0.00B$0.00B$0.00B$0.00B
Gross Profit$0.00B$0.00B$0.01B$0.00B$0.00B
Gross Margin %(computed)100.00%100.00%
Operating Expenses
R&D Expenses$0.02B$0.05B$0.05B$0.04B$0.03B
G&A Expenses$0.02B$0.01B$0.01B$0.01B$0.01B
Total Operating Expenses$0.04B$0.06B$0.06B$0.05B$0.04B
Operating Income($0.04B)($0.06B)($0.05B)($0.05B)($0.04B)
Operating Margin %(computed)-515.34%
Interest Income$0.00B$0.00B$0.00B$0.00B$0.00B
Interest Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Income Before Tax($0.04B)($0.05B)($0.05B)($0.05B)($0.04B)
Income Tax Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Net Income($0.04B)($0.05B)($0.05B)($0.05B)($0.04B)
Net Margin %(computed)-474.96%
Per Share & EBITDA
EPS (Basic)$-50.83$-96.75$-93.00$-72.00$-68.25
Wtd Avg Shares0.00B0.00B0.00B0.00B0.00B
EBITDA($0.04B)($0.05B)($0.05B)($0.05B)($0.04B)
EBITDA Margin %(computed)-469.48%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · B

深入了解Spruce Biosciences, Inc.

关于Spruce Biosciences, Inc.(SPRB)损益表

Spruce Biosciences, Inc.(SPRB)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,SPRB实现营收$0.00B,毛利润$0.00B(毛利率—),净利润($0.04B)(净利率—)。

常见问题

SPRB · 4 问

Spruce Biosciences, Inc.(SPRB)2025财年营收为$0.00B,同比down100.0%。

SPRB revenueSPRB salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09